GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-1 protease NL4-3 L89V mutant in complex with darunavir

Analyse Crystal structure of HIV-1 protease NL4-3 L89V mutant in complex with darunavir in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6OOU
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NL4-3 protease
UniProt
Q7ZCR0
Ligands
017, SO4
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, ANL4-3 proteaseprotein994% helix, 55% strandQ7ZCR0

Ligands and binding sites

  • 017 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate · ligand · chains B, A
  • SO4 · Sulfate ion · ion · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13720.730.8435017

Interfaces

1 interface between chains.

  • B–A · 1866 Ų buried · 43 hydrogen bonds · protein-protein

Compared structures

  • 6OOU · Crystal structure of HIV-1 Protease NL4-3 L89V Mutant in complex with darunavir · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.